Document Type
Article
Publication Date
6-4-2025
Abstract
The REnal cancer consortium for Focused Investigation of Novel biomarkers and Expression (REFINE) consortium represents an important initiative in integrating clinical data with molecular sequencing in patients with advanced renal cell carcinoma (RCC) treated with immunotherapy-based approaches. By leveraging real-world evidence and genomic analysis, this consortium aims to explore putative predictive biomarkers with the potential to inform personalized treatment strategies. Findings from the REFINE database may further contribute to our understanding of disease courses of immunotherapy-based approaches for various molecular subtypes of RCC, associations of race and ethnicity with RCC treatment and outcomes with representation of patient populations underrepresented in clinical trials, and optimizing treatment sequencing.
Recommended Citation
Zhong, Jeffrey; Jang, Albert; Abuqayas, Bashar; Basu, Arnab; Benjamin, David; Bhatlapenumarthi, Vineel; Bilen, Mehmet Asim; Buch, Dhvani; Chang, Mark; Chin, Erica; Darabi, Sourat; Dhanikonda, Nagendra; Ghatalia, Pooja; Grigg, Claud; Grier, Abby; Jindal, Tanya; Jung, Joannah; Kilari, Deepak; Kumar, Hamsa; Lee, Suzanna; Neelands, Brittany; Pandya, Chinmayi; Pawalek, Jeff; Staggers, Jaimee; Yildirim, Ahmet; Zakharia, Yousef; Zarrabi, Kevin; Zimmerman, Michael; Sledge, George; Spetzler, David; Elliott, Andrew; McKay, Rana; and Barata, Pedro, "REFINE: A Database of Linked Clinical Data and Genomic Biomarkers in Renal Cell Carcinoma Patients Receiving Immunotherapy-Based Treatment Regimens" (2025). Department of Medical Oncology Faculty Papers. Paper 303.
https://jdc.jefferson.edu/medoncfp/303
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.
PubMed ID
40536267
Language
English
Included in
Biological Factors Commons, Biomedical Informatics Commons, Neoplasms Commons, Oncology Commons


Comments
This article is the author's final published version in Oncologist, Volume 30, Issue 6, June 2025, oyaf135.
The published version is available at https://doi.org/10.1093/oncolo/oyaf135.
Copyright © The Author(s) 2025